Today: 1 May 2026
Citigroup stock drops after earnings: Russia hit, cost cuts in focus
14 January 2026
2 mins read

Citigroup stock drops after earnings: Russia hit, cost cuts in focus

New York, Jan 14, 2026, 11:57 a.m. EST — Regular session ongoing.

  • Shares of Citigroup dropped close to 4% following the release of its quarterly earnings
  • A $1.2 billion loss tied to Russia dragged on reported profits, but adjusted EPS still beat expectations
  • Expense control, headcount reductions, and hitting a 2026 profit goal remain key investor concerns

Citigroup shares dropped Wednesday following the release of its fourth-quarter results, as investors balanced gains from dealmaking-driven revenue against losses linked to its planned exit from Russia. The stock slid roughly 3.8% to $111.93, trading within a range of $118.50 to $111.93.

The reaction is crucial as major U.S. banks shape early-year risk appetite, with Citi’s stock standing out as one of the sector’s more notable turnaround plays. Traders are looking for evidence that higher investment banking and services fees can balance out the challenges of managing a vast global bank during its restructuring.

It comes as Citi ramps up efforts to close the profitability gap with competitors. The bank has focused heavily on capital returns and simplifying operations; this quarter will reveal if that approach is still paying off or just driving up costs.

Citi reported fourth-quarter net income of $2.5 billion, or $1.19 per diluted share, on $19.9 billion in revenue. The results factored in a $1.2 billion loss on the sale related to its plan to offload AO Citibank in Russia. Stripping out that charge, earnings came in at $1.81 per share. Operating expenses rose 6% to $13.8 billion.

Investment banking fees jumped 35% to $1.29 billion in the quarter, while revenue in the banking unit surged 78% to $2.2 billion, according to Reuters. David Wagner, equity head and portfolio manager at Aptus Capital Advisors, described it as a sign Citi’s turnaround is gaining steam. He added, “Citigroup could be officially shedding its laggard reputation.” Reuters

The selloff highlighted just how sensitive the market remains. Citi’s return on tangible common equity (RoTCE) — which excludes goodwill and other intangibles — came in at 5.1% this quarter, far short of its 10%-11% target for 2026. Meanwhile, expenses climbed higher.

Cost control is heating up. Citigroup plans to slash roughly 1,000 jobs this week, according to a source speaking to Reuters. The cuts are part of a larger effort to trim headcount. A company spokesperson said these moves are simply staffing tweaks to align with current demands.

The bank also pointed out it still has capacity to return cash. On Monday, Citi’s board approved a quarterly common dividend of $0.60 per share, set for payment on Feb. 27 to shareholders of record as of Feb. 2.

Citi’s report arrived during a packed week for the sector. JPMorgan released its results Tuesday, followed by Bank of America and Wells Fargo on Wednesday. Investors are reassessing how trading, lending, and deal fees will shape 2026.

The path isn’t straightforward. Should the deal pipeline slow or lower interest rates compress net interest income — the gap between what banks make on loans versus what they pay on deposits — the boost from investment banking and services might dwindle, leaving Citi with less cushioning against climbing costs.

Investors are now focused on whether management will maintain the 10%-11% RoTCE goal for 2026, and how swiftly expenses and headcount begin to drop with the newest round of cuts. The next key dates for shareholders are the Feb. 2 record date and the Feb. 27 dividend payout.

Stock Market Today

  • Cocoa Prices Rise on Strong Chocolate Demand and Supply Concerns
    May 1, 2026, 1:54 PM EDT. Cocoa prices are climbing, with July ICE London cocoa hitting a 2.5-month high, supported by steady consumer demand for chocolate and smaller global surplus forecasts. Top chocolate makers Hershey and Mondelez reported better-than-expected earnings, indicating resilient demand despite high prices. StoneX lowered its global surplus outlook due to possible crop risks from El Niño, while disruptions from the Strait of Hormuz closure are increasing costs for cocoa importers. However, weak cocoa grindings in North America and Europe and declining chocolate sales pose downward pressure. Current cocoa supplies remain abundant, notably with a 20-month high in ICE inventories, though stable shipments from Ivory Coast and declining Nigerian exports add complexity to the market outlook.

Latest article

Dow Jones Today: Why the Blue-Chip Rally Stalled as Apple, S&P 500 and Nasdaq Pushed Higher

Dow Jones Today: Why the Blue-Chip Rally Stalled as Apple, S&P 500 and Nasdaq Pushed Higher

1 May 2026
The Dow Jones Industrial Average fell 78.72 points to 49,573.42 by midday Friday, reversing an early rally as tariff concerns weighed on gains from Apple and other strong earnings reports. President Donald Trump announced a 25% tariff on EU-made cars and trucks starting next week. Apple reported quarterly revenue of $111.2 billion, up 17% year over year. Oil prices dropped after Iran sent a new negotiation proposal.
US Stock Market Today: Why the S&P 500 and Nasdaq Are Hitting Fresh Highs

US Stock Market Today: Why the S&P 500 and Nasdaq Are Hitting Fresh Highs

1 May 2026
The S&P 500 rose 0.48% and the Nasdaq 0.96% to record highs Friday, while the Dow slipped 0.11%. Apple shares climbed after reporting its strongest quarterly sales growth in over four years. Atlassian and other software stocks rallied on strong cloud demand. Exxon and Chevron beat profit estimates but cited pressure from Middle East conflict and volatile oil prices.
Recursion Pharmaceuticals Stock: Founder Chris Gibson to Leave Board as RXRX Nears Q1 Earnings

Recursion Pharmaceuticals Stock: Founder Chris Gibson to Leave Board as RXRX Nears Q1 Earnings

1 May 2026
Recursion Pharmaceuticals said founder and board chair Chris Gibson will not seek re-election at the June 17 annual meeting, months after stepping down as CEO. The company reports first-quarter results May 6, with investors watching for updates on cash, clinical progress, and its AI drug platform. Recursion last reported $753.9 million in cash and narrowed its quarterly net loss. Gibson will remain chair until his term ends.
Pfizer stock rises as CEO likens obesity-drug boom to Viagra ahead of Feb. 3 earnings
Previous Story

Pfizer stock rises as CEO likens obesity-drug boom to Viagra ahead of Feb. 3 earnings

Applied Materials stock drops despite Stifel’s $340 target hike — what AMAT investors watch next
Next Story

Applied Materials stock drops despite Stifel’s $340 target hike — what AMAT investors watch next

Go toTop